New Gen5 v1.06 Offers Enhanced Data Evaluation, Including Parallel Line Analysis

September 26, 2008

Recognizing the importance of bioassay statistical analysis in drug discovery, HTS and other research markets, BioTek Instruments, Inc., has incorporated Parallel Line Analysis in the new Gen5 Data Analysis Software version 1.06. Parallelism analysis can be made with Gen5's linear regression, 4-parameter and 5-parameter logistic fits.

Multiple curve metrics and detailed statistics are available to ensure the most accurate estimations of parallelism and relative potency between the experimental curves and control curves. Along with parallel line analysis, Gen5 v1.06 offers a number of enhancements designed to combine powerful analysis tools with unsurpassed ease of use including color gradient data views, individual patient reports, use of curve parameters in data transformations and more.

BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research. Founded in 1968, BioTek Instruments is celebrating its 40th anniversary this year.

For further information, contact:

Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications
908-668-1106 x15